Healthtech funding in 2010
European Healthtech startup funding raised during 2010.
In 2010, 44 European Healthtech companies closed 45 funding rounds and raised €346M in equity funding (excluding debt and grants). France led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 6 Nov 2026.
Equity funding
€346M
excl. debt & grants
Funding rounds
45
Companies
44
Top country
France
Healthtech: last three years
change vs the year before| Year | Equity | Change | Rounds | Change | Debt |
|---|---|---|---|---|---|
| 2008 | €76M | -13.4% | 15 | +15.4% | — |
| 2009 | €277M | +263.8% | 26 | +73.3% | — |
| 2010 | €346M | +24.9% | 45 | +73.1% | — |
Rank among sectors
#3
10.0% of sector funding
Top-10 round share
64.9%
of disclosed capital
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, 2010 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €27M | 5 |
| Mar | €46M | 4 |
| Apr | €74M | 7 |
| May | €52M | 4 |
| Jun | €7.7M | 3 |
| Jul | €48M | 6 |
| Aug | €4.4M | 2 |
| Sep | €27M | 7 |
| Oct | €8.1M | 5 |
| Nov | €35M | 1 |
| Dec | €17M | 1 |
Top countries
by € raisedHealthtech — top countries by capital, 2010 — interactive chart.
Data table
| Healthtech — top countries by capital, 2010 | |
|---|---|
| France | €88M |
| Switzerland | €69M |
| Germany | €66M |
| UK | €65M |
| Israel | €35M |
| Spain | €8.1M |
| Ireland | €7.5M |
| Finland | €5.8M |
Stage mix
by € raisedHealthtech — stage mix, 2010 — interactive chart.
Data table
| Healthtech — stage mix, 2010 | |
|---|---|
| Series C | €115M |
| Series B | €74M |
| Other | €59M |
| Series A | €50M |
| Early VC | €24M |
| Series D+ | €22M |
| Seed | €1.2M |
| Grant | €656k |
Largest equity rounds
by disclosed amount, 2010| Company | Stage | Date | Amount |
|---|---|---|---|
| SuperSonic Imagine | Series C | Nov 2010 | €35M |
| Biocartis | Series B | Apr 2010 | €30M |
| CureVac | Series C | May 2010 | €26M |
| Kymab | Series A | Jul 2010 | €25M |
| WILEX | Other | Mar 2010 | €24M |
| Oxford Nanopore Technologies | Series C | Apr 2010 | €21M |
| CeQur | Series A | Jan 2010 | €21M |
| NovImmune | Series D+ | Dec 2010 | €17M |
| Genticel | Series C | Apr 2010 | €13M |
| Valtech Cardio | Series B | Mar 2010 | €13M |
Top investors
most active in 2010, by deal count- High-Tech Gründerfonds (HTGF)3 deals
- Amundi Private Equity Funds2 deals
- Aurinvest2 deals
- Pitango Venture Capital2 deals
- Ventech2 deals
- Advent Venture Partners1 deals
- Aescap1 deals
- Bayern Kapital1 deals
- BNP Paribas1 deals
- BZ Bank1 deals
Source: Tech.eu Funding Explorer · data as of 6 Nov 2026 · licence CC BY 4.0 · Methodology